CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,314,000 | -45.5% | 6,637,222 | +24.2% | 0.00% | -50.0% |
| Q3 2018 | $2,410,000 | -3.1% | 5,343,599 | +22.1% | 0.00% | +100.0% |
| Q2 2018 | $2,486,000 | +590.6% | 4,375,101 | +2733.4% | 0.00% | – |
| Q1 2018 | $360,000 | -37.4% | 154,414 | -23.3% | 0.00% | -100.0% |
| Q3 2017 | $575,000 | -33.2% | 201,214 | -42.3% | 0.00% | 0.0% |
| Q2 2017 | $861,000 | -86.0% | 348,614 | -79.6% | 0.00% | -88.9% |
| Q1 2017 | $6,166,000 | +45.2% | 1,707,927 | +42.4% | 0.01% | +28.6% |
| Q4 2016 | $4,247,000 | -16.4% | 1,199,710 | -4.6% | 0.01% | -22.2% |
| Q3 2016 | $5,083,000 | +49.1% | 1,258,214 | +62.0% | 0.01% | +50.0% |
| Q2 2016 | $3,410,000 | +10.9% | 776,800 | -4.5% | 0.01% | 0.0% |
| Q1 2016 | $3,074,000 | – | 813,331 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |